AustralieFrV1, Main, Exploration, bibRecord, 001C38

International trends in liver cancer incidence, overall and by histologic subtype, 1978–2007

Identifieur interne : 001C38 ( Main/Exploration ); précédent : 001C37; suivant : 001C39

International trends in liver cancer incidence, overall and by histologic subtype, 1978–2007

Auteurs : Jessica L. Petrick [États-Unis] ; Megan Braunlin [États-Unis] ; Mathieu Laversanne [France] ; Patricia Valery [Australie] ; Freddie Bray [France] ; Katherine A. Mcglynn [États-Unis]

Source :

International journal of cancer [ 0020-7136 ] ; 2016.

RBID : PMC:5310166

Descripteurs français

KwdFr :
- Adulte, Adulte d'âge moyen, Carcinome hépatocellulaire (anatomopathologie), Carcinome hépatocellulaire (épidémiologie), Cholangiocarcinome (anatomopathologie), Cholangiocarcinome (épidémiologie), Facteurs de l'âge, Facteurs sexuels, Femelle, Humains, Incidence, Internationalité, Mâle, Santé mondiale, Sujet âgé, Sujet âgé de 80 ans ou plus, Tumeurs du foie (anatomopathologie), Tumeurs du foie (épidémiologie), Études de cohortes.
MESH :
- anatomopathologie : Carcinome hépatocellulaire, Cholangiocarcinome, Tumeurs du foie.
- épidémiologie : Carcinome hépatocellulaire, Cholangiocarcinome, Tumeurs du foie.
- Adulte, Adulte d'âge moyen, Facteurs de l'âge, Facteurs sexuels, Femelle, Humains, Incidence, Internationalité, Mâle, Santé mondiale, Sujet âgé, Sujet âgé de 80 ans ou plus, Études de cohortes.

English descriptors

KwdEn :
- Adult, Age Factors, Aged, Aged, 80 and over, Carcinoma, Hepatocellular (epidemiology), Carcinoma, Hepatocellular (pathology), Cholangiocarcinoma (epidemiology), Cholangiocarcinoma (pathology), Cohort Studies, Female, Global Health, Humans, Incidence, Internationality, Liver Neoplasms (epidemiology), Liver Neoplasms (pathology), Male, Middle Aged, Sex Factors.
MESH :
- epidemiology : Carcinoma, Hepatocellular, Cholangiocarcinoma, Liver Neoplasms.
- pathology : Carcinoma, Hepatocellular, Cholangiocarcinoma, Liver Neoplasms.
- Adult, Age Factors, Aged, Aged, 80 and over, Cohort Studies, Female, Global Health, Humans, Incidence, Internationality, Male, Middle Aged, Sex Factors.

Abstract

Primary liver cancer, the most common histologic types of which are hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), is the second leading cause of cancer death worldwide. While rising incidence of liver cancer in low-risk areas and decreasing incidence in some high-risk areas has been reported, trends have not been thoroughly explored by country or by histologic type. We examined liver cancer incidence overall and by histology by calendar time and birth cohort for selected countries between 1978 and 2007. For each successive 5-year period, age-standardized incidence rates were calculated from volumes V-IX of the Cancer Incidence in Five Continents electronic database (CI5plus) and the newly released CI5X (volume X) database. Wide global variations persist in liver cancer incidence. Rates of liver cancer remain highest in Asian countries, specifically Eastern and South-Eastern Asian countries. While rates in most of these high-risk countries have been decreasing in recent years, rates in India and several low-risk countries of Africa, Europe, the Americas, and Oceania have been on the rise. Liver cancer rates by histologic type tend to convey a similar temporal profile. However, in Thailand, France, and Italy, ICC rates have increased while HCC rates have declined. We expect rates in high-risk countries to continue to decrease, as the population seroprevalence of hepatitis B virus (HBV) continues to decline. In low-risk countries, targeted screening and treatment of the hepatitis C virus (HCV), treatment of diabetes and primary prevention of obesity, will be key in reducing future liver cancer incidence.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310166

DOI: 10.1002/ijc.30211
PubMed: 27244487
PubMed Central: 5310166

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">International trends in liver cancer incidence, overall and by histologic subtype, 1978–2007</title>
<author><name sortKey="Petrick, Jessica L" sort="Petrick, Jessica L" uniqKey="Petrick J" first="Jessica L." last="Petrick">Jessica L. Petrick</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Braunlin, Megan" sort="Braunlin, Megan" uniqKey="Braunlin M" first="Megan" last="Braunlin">Megan Braunlin</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Laversanne, Mathieu" sort="Laversanne, Mathieu" uniqKey="Laversanne M" first="Mathieu" last="Laversanne">Mathieu Laversanne</name>
<affiliation wicri:level="3"><nlm:aff id="A2">Cancer Surveillance Section, International Agency for Research on Cancer, Lyon, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Cancer Surveillance Section, International Agency for Research on Cancer, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Valery, Patricia" sort="Valery, Patricia" uniqKey="Valery P" first="Patricia" last="Valery">Patricia Valery</name>
<affiliation wicri:level="1"><nlm:aff id="A3">QIMR Berghofer Medical Research Institute, Brisbane, Australia</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>QIMR Berghofer Medical Research Institute, Brisbane</wicri:regionArea>
<wicri:noRegion>Brisbane</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bray, Freddie" sort="Bray, Freddie" uniqKey="Bray F" first="Freddie" last="Bray">Freddie Bray</name>
<affiliation wicri:level="3"><nlm:aff id="A2">Cancer Surveillance Section, International Agency for Research on Cancer, Lyon, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Cancer Surveillance Section, International Agency for Research on Cancer, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mcglynn, Katherine A" sort="Mcglynn, Katherine A" uniqKey="Mcglynn K" first="Katherine A." last="Mcglynn">Katherine A. Mcglynn</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">27244487</idno>
<idno type="pmc">5310166</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310166</idno>
<idno type="RBID">PMC:5310166</idno>
<idno type="doi">10.1002/ijc.30211</idno>
<date when="2016">2016</date>
<idno type="wicri:Area/Pmc/Corpus">001C60</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001C60</idno>
<idno type="wicri:Area/Pmc/Curation">001B18</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001B18</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000827</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000827</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="wicri:Area/PubMed/Corpus">001843</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001843</idno>
<idno type="wicri:Area/PubMed/Curation">001820</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001820</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001820</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001820</idno>
<idno type="wicri:Area/Ncbi/Merge">003613</idno>
<idno type="wicri:Area/Ncbi/Curation">003613</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003613</idno>
<idno type="wicri:doubleKey">0020-7136:2016:Petrick J:international:trends:in</idno>
<idno type="wicri:Area/Main/Merge">001C35</idno>
<idno type="wicri:Area/Main/Curation">001C38</idno>
<idno type="wicri:Area/Main/Exploration">001C38</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">International trends in liver cancer incidence, overall and by histologic subtype, 1978–2007</title>
<author><name sortKey="Petrick, Jessica L" sort="Petrick, Jessica L" uniqKey="Petrick J" first="Jessica L." last="Petrick">Jessica L. Petrick</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Braunlin, Megan" sort="Braunlin, Megan" uniqKey="Braunlin M" first="Megan" last="Braunlin">Megan Braunlin</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Laversanne, Mathieu" sort="Laversanne, Mathieu" uniqKey="Laversanne M" first="Mathieu" last="Laversanne">Mathieu Laversanne</name>
<affiliation wicri:level="3"><nlm:aff id="A2">Cancer Surveillance Section, International Agency for Research on Cancer, Lyon, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Cancer Surveillance Section, International Agency for Research on Cancer, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Valery, Patricia" sort="Valery, Patricia" uniqKey="Valery P" first="Patricia" last="Valery">Patricia Valery</name>
<affiliation wicri:level="1"><nlm:aff id="A3">QIMR Berghofer Medical Research Institute, Brisbane, Australia</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>QIMR Berghofer Medical Research Institute, Brisbane</wicri:regionArea>
<wicri:noRegion>Brisbane</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bray, Freddie" sort="Bray, Freddie" uniqKey="Bray F" first="Freddie" last="Bray">Freddie Bray</name>
<affiliation wicri:level="3"><nlm:aff id="A2">Cancer Surveillance Section, International Agency for Research on Cancer, Lyon, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Cancer Surveillance Section, International Agency for Research on Cancer, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mcglynn, Katherine A" sort="Mcglynn, Katherine A" uniqKey="Mcglynn K" first="Katherine A." last="Mcglynn">Katherine A. Mcglynn</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">International journal of cancer</title>
<idno type="ISSN">0020-7136</idno>
<idno type="eISSN">1097-0215</idno>
<imprint><date when="2016">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Carcinoma, Hepatocellular (epidemiology)</term>
<term>Carcinoma, Hepatocellular (pathology)</term>
<term>Cholangiocarcinoma (epidemiology)</term>
<term>Cholangiocarcinoma (pathology)</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Global Health</term>
<term>Humans</term>
<term>Incidence</term>
<term>Internationality</term>
<term>Liver Neoplasms (epidemiology)</term>
<term>Liver Neoplasms (pathology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Sex Factors</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Carcinome hépatocellulaire (anatomopathologie)</term>
<term>Carcinome hépatocellulaire (épidémiologie)</term>
<term>Cholangiocarcinome (anatomopathologie)</term>
<term>Cholangiocarcinome (épidémiologie)</term>
<term>Facteurs de l'âge</term>
<term>Facteurs sexuels</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Internationalité</term>
<term>Mâle</term>
<term>Santé mondiale</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tumeurs du foie (anatomopathologie)</term>
<term>Tumeurs du foie (épidémiologie)</term>
<term>Études de cohortes</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Carcinome hépatocellulaire</term>
<term>Cholangiocarcinome</term>
<term>Tumeurs du foie</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Carcinoma, Hepatocellular</term>
<term>Cholangiocarcinoma</term>
<term>Liver Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Carcinoma, Hepatocellular</term>
<term>Cholangiocarcinoma</term>
<term>Liver Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Carcinome hépatocellulaire</term>
<term>Cholangiocarcinome</term>
<term>Tumeurs du foie</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Global Health</term>
<term>Humans</term>
<term>Incidence</term>
<term>Internationality</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Sex Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Facteurs de l'âge</term>
<term>Facteurs sexuels</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Internationalité</term>
<term>Mâle</term>
<term>Santé mondiale</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études de cohortes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P1">Primary liver cancer, the most common histologic types of which are hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), is the second leading cause of cancer death worldwide. While rising incidence of liver cancer in low-risk areas and decreasing incidence in some high-risk areas has been reported, trends have not been thoroughly explored by country or by histologic type. We examined liver cancer incidence overall and by histology by calendar time and birth cohort for selected countries between 1978 and 2007. For each successive 5-year period, age-standardized incidence rates were calculated from volumes V-IX of the <italic>Cancer Incidence in Five Continents</italic>
 electronic database (CI5<italic>plus</italic>
) and the newly released CI5X (volume X) database. Wide global variations persist in liver cancer incidence. Rates of liver cancer remain highest in Asian countries, specifically Eastern and South-Eastern Asian countries. While rates in most of these high-risk countries have been decreasing in recent years, rates in India and several low-risk countries of Africa, Europe, the Americas, and Oceania have been on the rise. Liver cancer rates by histologic type tend to convey a similar temporal profile. However, in Thailand, France, and Italy, ICC rates have increased while HCC rates have declined. We expect rates in high-risk countries to continue to decrease, as the population seroprevalence of hepatitis B virus (HBV) continues to decline. In low-risk countries, targeted screening and treatment of the hepatitis C virus (HCV), treatment of diabetes and primary prevention of obesity, will be key in reducing future liver cancer incidence.</p>
</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
<li>France</li>
<li>États-Unis</li>
</country>
<region><li>Auvergne-Rhône-Alpes</li>
<li>Maryland</li>
<li>Rhône-Alpes</li>
</region>
<settlement><li>Lyon</li>
</settlement>
</list>
<tree><country name="États-Unis"><region name="Maryland"><name sortKey="Petrick, Jessica L" sort="Petrick, Jessica L" uniqKey="Petrick J" first="Jessica L." last="Petrick">Jessica L. Petrick</name>
</region>
<name sortKey="Braunlin, Megan" sort="Braunlin, Megan" uniqKey="Braunlin M" first="Megan" last="Braunlin">Megan Braunlin</name>
<name sortKey="Mcglynn, Katherine A" sort="Mcglynn, Katherine A" uniqKey="Mcglynn K" first="Katherine A." last="Mcglynn">Katherine A. Mcglynn</name>
</country>
<country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Laversanne, Mathieu" sort="Laversanne, Mathieu" uniqKey="Laversanne M" first="Mathieu" last="Laversanne">Mathieu Laversanne</name>
</region>
<name sortKey="Bray, Freddie" sort="Bray, Freddie" uniqKey="Bray F" first="Freddie" last="Bray">Freddie Bray</name>
</country>
<country name="Australie"><noRegion><name sortKey="Valery, Patricia" sort="Valery, Patricia" uniqKey="Valery P" first="Patricia" last="Valery">Patricia Valery</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C38 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001C38 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:5310166
   |texte=   International trends in liver cancer incidence, overall and by histologic subtype, 1978–2007
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:27244487" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

Serveur d'exploration sur les relations entre la France et l'Australie

International trends in liver cancer incidence, overall and by histologic subtype, 1978–2007

International trends in liver cancer incidence, overall and by histologic subtype, 1978–2007

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.